Atnaujinkite slapukų nuostatas

Immunodeficient Animals: Models for Cancer Research [Kietas viršelis]

Edited by , Series edited by , Edited by , Edited by , Series edited by
  • Formatas: Hardback, 230 pages, weight: 585 g, 88 fig., 38 tab.; 88 Illustrations
  • Serija: Contributions to Oncology 51
  • Išleidimo metai: 07-May-1996
  • Leidėjas: S Karger AG
  • ISBN-10: 3805562705
  • ISBN-13: 9783805562706
Kitos knygos pagal šią temą:
  • Formatas: Hardback, 230 pages, weight: 585 g, 88 fig., 38 tab.; 88 Illustrations
  • Serija: Contributions to Oncology 51
  • Išleidimo metai: 07-May-1996
  • Leidėjas: S Karger AG
  • ISBN-10: 3805562705
  • ISBN-13: 9783805562706
Kitos knygos pagal šią temą:
The classic immunodeficient mutants nude, scid and rnu have an important function in experimental cancer research: they allow unique methods of investigation and provide data of clinical relevance. This volume presents the state of the art of research work based on the use of these immunodeficient animal models. One section is dedicated to the biological aspects and immunological properties of immunodeficient mutants. Another part includes articles on xenogenous transplantation of human tumors, focusing on the establishment of transplantable lines, growth characteristics and tumor markers. Special attention is given to new approaches in the fields of chemotherapy, radiation therapy and immunotherapy. Various contributors consider in vitro methods as alternative models. In addition to current data, this publication contains useful technical and methodological information and is therefore valuable not only for specialists but also for scientists entering the field of experimental cancer research.
Part 1 Immunodeficient mutants - biological features and specific
models: biology; immunological properties; non-cancerous models; autochtonous
tumours. Part 2 Xenogenous transplantation of human tumours - establishment
of transplantable lines and growth characteristics: establishing
transplantable lines; growth characteristics; tumour markers. Part 3
Chemotherapy models - screening and therapy approaches: screening studies;
therapy approaches. Part 4 Radiation therapy approaches: radiotherapy;
sensitizers. Part 5 Immunotherapy models: xenogenization of SCID mice; tumour
therapy approaches; in vitro methods as alternative models.